291650 is the Korean stock ticker for Aptamer Sciences, a KOSDAQ-listed Korean public company in Business Services & Distribution.
291650 is the Korean stock ticker for Aptamer Sciences, a KOSDAQ-listed Korean public company in Business Services & Distribution. Business activity: Aptamer-based therapeutic and diagnostic product research and development. Product/service: Customized analytical services and regulatory consulting. Product/service: Nonclinical toxicokinetic and clinical pharmacokinetic analytical services. Product/service: Aptamer services. Product/service: Consumer goods.
This ticker has no publisher-linked research report in the current collection.
291650 is a Korean stock ticker that trades on KOSDAQ as a common share tracked by Korean Tickers with data.go.kr daily public data, DART filings, and USD reference values.
Aptamer Sciences is classified by Korean Tickers under Business Services & Distribution, with official issuer and industry context shown on the company profile.
| Item | TTM 26 Q1 LTM / latest balance sheet | 26 Q1 Standalone quarter | 2025 Annual | 2024 Annual | Change vs 2025 |
|---|---|---|---|---|---|
| Revenue | $2.62M ₩3.6B | $512K ₩706.9M | $2.54M ₩3.5B | $785K ₩1.1B | +3.2% |
| Gross Profit | $1.32M ₩1.8B | $261K ₩359.8M | $1.22M ₩1.7B | $559K ₩772.0M | +7.7% |
| Operating Income | $-5.11M ₩-7.1B | $-1.08M ₩-1.5B | $-5.65M ₩-7.8B | $-5.11M ₩-7.1B | +9.5% |
| Net Income | $-6.38M ₩-8.8B | $-1.71M ₩-2.4B | $-6.25M ₩-8.6B | $-6.31M ₩-8.7B | -2.1% |
| Cash & Equivalents | $13.70M ₩18.9B | $13.70M ₩18.9B | $15.49M ₩21.4B | $8.31M ₩11.5B | -11.6% |
| Current Assets | $21.78M ₩30.1B | $21.78M ₩30.1B | $18.74M ₩25.9B | $13.65M ₩18.8B | +16.2% |
| Receivables | - | - | $566K ₩781.1M | $147K ₩203.1M | |
| Inventory | $969K ₩1.3B | $969K ₩1.3B | $1.10M ₩1.5B | $15K ₩21.3M | -11.7% |
| Total Assets | $33.29M ₩45.9B | $33.29M ₩45.9B | $29.79M ₩41.1B | $23.17M ₩32.0B | +11.7% |
| Current Liabilities | $13.21M ₩18.2B | $13.21M ₩18.2B | $8.53M ₩11.8B | $2.82M ₩3.9B | +54.9% |
| Total Liabilities | $13.91M ₩19.2B | $13.91M ₩19.2B | $9.33M ₩12.9B | $4.74M ₩6.5B | +49.1% |
| Total Equity | $19.38M ₩26.7B | $19.38M ₩26.7B | $20.46M ₩28.2B | $18.43M ₩25.4B | -5.3% |